The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
about
Melanocortin peptides: potential targets in systemic lupus erythematosusSmall molecules in the treatment of systemic lupus erythematosusLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusIL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment.Cytokines in autoimmunity: role in induction, regulation, and treatment.Interferons in autoimmune and inflammatory diseases: regulation and roles.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosusArginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus.Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritisC/EBP β mRNA expression is upregulated and positively correlated with the expression of TNIP1/TNFAIP3 in peripheral blood mononuclear cells from patients with systemic lupus erythematosusRe-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons.IL-1β and IL-6 Are Highly Expressed in RF+IgE+ Systemic Lupus Erythematous SubtypeType I IFN-mediated regulation of IL-1 production in inflammatory disorders.PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?Contributions of B cells to lupus pathogenesisClinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key IndicationsIL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.Upregulation of the C/EBP β LAP isoform could be due to decreased TNFAIP3/TNIP1 expression in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.Resistin as a potential marker of renal disease in lupus nephritis.iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling.Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.The phenolic fraction of extra virgin olive oil modulates the activation and the inflammatory response of T cells from patients with systemic lupus erythematosus and healthy donors.Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid ArthritisCytokine profiling in active and quiescent SLE reveals distinct patient subpopulations
P2860
Q26865343-60B925C0-571F-4777-BB41-A62124BE6036Q27010090-3E58E667-40E4-471E-8116-634DE41D8686Q28268802-7AD94256-0B0F-4F5E-A9F5-C8AFE9E53899Q35078183-C785B461-3E27-48CC-BA8A-43D5F9AD9B34Q35294424-78D8BC7E-A9A4-4E74-BCBB-80CC2A7091E0Q35603598-94A88654-D3A8-4BE1-8A6D-29D2AA5A4B3FQ35625089-6C238DF4-C51B-40EC-9F52-A7358E5DF0B9Q36492750-B1924B69-0386-4C56-8B6E-E25A78E9BBDAQ36974463-E1F8A575-86E4-4351-A8A2-3CA5315157CEQ37058781-E33F0E2D-BBEA-4BB6-A30C-2AB01C306809Q37221965-49DDA6A3-3448-4EEC-969E-21DF9BA6A6EFQ37288290-140A7CEA-E48F-46EA-9D6B-1A0B8BCA4F80Q37576728-C0D1679A-B346-40B2-BCE4-05448FA7CACBQ37670861-74670485-6241-49B0-9FDD-69C5186C3AE3Q38004932-4D6B9CAF-AD60-453F-A1D4-EB59148C62CCQ38132128-B4586EF3-2105-4BE1-9C62-A34E0024F51AQ38170793-5E763CE1-D477-4335-9C04-F04AFCB33F4AQ38703169-DC214340-49E7-4D6A-A0EB-5850C7FB8769Q39729327-E33E6816-A299-4EFB-96D8-9F134714D9ECQ40530266-6B5DE7EC-2AB6-4AA9-84A4-3DA220F64BB8Q40599790-E5618B5C-8650-47F8-8CFB-81EC0683F706Q44209888-831D9593-11DD-4B4C-82A8-931D445342FBQ49709167-A7219147-8954-42A3-9AF9-DEEB08D52DE8Q50926293-E4B9E980-2D9C-4BEC-ADE1-8A0A8A405F9EQ51137468-2E9F4E95-9F7E-40B4-B631-9300376D8918Q55401570-29AA72CE-A3E7-4BD1-854D-3DAC5BBDF536Q58780906-19DEBE01-4A75-4135-A9E7-FA783022B4B7Q58793379-8BB49D27-4AB7-4B8C-94EB-EBBA381DF450
P2860
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
@ast
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
@en
type
label
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
@ast
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
@en
prefLabel
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
@ast
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
@en
P2093
P2860
P356
P1476
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
@en
P2093
Chandra Mohan
Jack Hutcheson
Laurie S Davis
P2860
P304
P356
10.1089/JIR.2011.0047
P577
2011-07-25T00:00:00Z